Biotech Stock News: Nova Mentis (CSE: NOVA) Welcomes Autism Behaviour Analyst to its Science Team


Vancouver, British Columbia – May 12, 2022 (Newsfile Corp.) ( Newswire) Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to welcome John Molinaro, a Board Certified Behaviour Analyst specializing in autism spectrum disorder therapy, to its Scientific Advisory Board.

Crypto Corner Podcast 833: Stocks discussed: (NasdaqGS: HUT) (NYSE: BKKT) (NasdaqCM: MIGI)

Previous article

Aztec Finds Gold in Step-Out Hole At Cervantes

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News